Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Journal of Cellular and Molecular Medicine
|
September 27, 2018
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer
Enrique Gómez-Gómez, Juan M Jiménez-Vacas, Julia Carrasco-Valiente, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 15, 2017
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer
Daniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Cancer Letters
|
October 4, 2016
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker
Daniel Hormaechea-Agulla, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, et al.
Journal of Clinical Medicine
|
September 11, 2019
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
Enrique Gómez-Gómez, Juan M. Jiménez-Vacas, Sergio Pedraza-Arévalo, et al.
Molecular Therapy. Oncology
|
January 6, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, et al.
The Prostate
|
May 7, 2025
Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence
Laura Chamorro Castillo, Inés Rivero Belenchón, Ignacio Puche Sanz, et al.
Molecular Cancer
|
August 31, 2017
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Daniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, et al.
Molecular Therapy. Nucleic Acids
|
March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Science Advances
|
October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
Antonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Cell Communication and Signaling : CCS
|
May 15, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2
Jesús M Pérez-Gómez, Antonio Prats-Escribano, Ignacio Gil-Duque, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Journal of Cellular and Molecular Medicine
|
September 27, 2018
Plasma ghrelin O-acyltransferase (GOAT) enzyme levels: A novel non-invasive diagnosis tool for patients with significant prostate cancer
Enrique Gómez-Gómez, Juan M Jiménez-Vacas, Julia Carrasco-Valiente, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 15, 2017
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer
Daniel Hormaechea-Agulla, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Cancer Letters
|
October 4, 2016
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker
Daniel Hormaechea-Agulla, Enrique Gómez-Gómez, Alejandro Ibáñez-Costa, et al.
Journal of Clinical Medicine
|
September 11, 2019
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer
Enrique Gómez-Gómez, Juan M. Jiménez-Vacas, Sergio Pedraza-Arévalo, et al.
Molecular Therapy. Oncology
|
January 6, 2025
Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target
Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, Manuel Galán-Cañete, et al.
The Prostate
|
May 7, 2025
Multicenter External Validation and Optimization of a Proposed Nomogram for Prostate-Specific Membrane Antigen PET/CT Accuracy in Biochemical Recurrence
Laura Chamorro Castillo, Inés Rivero Belenchón, Ignacio Puche Sanz, et al.
Molecular Cancer
|
August 31, 2017
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness
Daniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, et al.
Molecular Therapy. Nucleic Acids
|
March 14, 2022
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
Vicente Herrero-Aguayo, Prudencio Sáez-Martínez, Juan M Jiménez-Vacas, et al.
Science Advances
|
October 2, 2024
SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer
Antonio J Montero-Hidalgo, Juan M Jiménez-Vacas, Enrique Gómez-Gómez, et al.
Cell Communication and Signaling : CCS
|
May 15, 2026
Periprostatic adipose tissue-derived adipokine profile in prostate cancer patients reveals two distinct molecular phenotypes linked to obesity-related comorbidities: multifaceted role of lipocalin-2
Jesús M Pérez-Gómez, Antonio Prats-Escribano, Ignacio Gil-Duque, et al.
Page
of 3